Dr. Jacob Michael Feagans, MD

Dr. Feagans practices at Borland Groover Clinic - HOPD in Santa Rosa Beach, Florida.

Dr. Feagans' NPI, 1932389681, was assigned on November 10, 2007. Dr. Feagans graduated from Mercer University School of Medicine in 2005. Dr. Feagans holds Florida license ME153671.

Dr. Feagans' primary practice is Borland Groover Clinic - HOPD, at 23 Mack Bayou Loop, STE 200, Santa Rosa Beach, FL 32459.

Dr. Feagans' primary practice is Borland Groover Clinic - HOPD in Santa Rosa Beach, Florida. Dr. Feagans is also affiliated with Ascension Sacred Heart Pensacola. The medical group on file is Borland Groover. Dmand AI also links Dr. Feagans to 3 more hospitals and 1 group practice or clinic, each named with a free account. Dr. Feagans' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Feagans practices, 6 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Feagans' primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Feagans is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Feagans' licenses on file in 3 states: Florida, Mississippi and Louisiana.

Dmand AI lists acid reflux, chronic inflammatory bowel disease (IBD), cirrhosis of the liver, colonoscopy, fatty liver, gastroenteritis, gastrointestinal bleeding and hemorrhoids among the conditions Dr. Feagans treats.

CMS data shows 2,169 Medicare services from Dr. Feagans across 18 procedure codes in 2024, for 856 Medicare patients. Medicare paid $218,231 for them.

CMS counts 856 Medicare patients who saw Dr. Feagans in 2024. The largest group is 65 to 74, with 464 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 3% are also on Medicaid. Their average risk score is 1.11, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Feagans' median patient age at 63, with 59% women.

In 2024, Dr. Feagans wrote 2,147 Medicare Part D claims for 633 patients. 75% of them were for generic drugs. CMS names the drug for 2,014 of them, across 41 drugs with 11 or more claims each, at $716,270 in total drug cost. In 2023, CMS named 1,389 claims across 30 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 79 out of 100 for Dr. Feagans for performance year 2024, reported as part of a group. Dr. Feagans accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 485 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Feagans, more than 98% of the clinicians it reports for that procedure.

Dmand AI links 4 papers to Dr. Feagans. The most frequent topics are Diagnosis, Differential. Dr. Feagans' most frequent co-authors are David W. Victor, MD and Jamie S. Barkin, MD.

CMS Open Payments shows 812 general payments to Dr. Feagans from 43 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Abbvie Inc. paid the most, $4,199.

Dmand AI lists 1 award for Dr. Feagans, most recently CMS Stage 1 EHR in 2013.

Dr. Feagans graduated from Mercer University School of Medicine in 2005.

Dr. Feagans is in network with 17 carriers, including Aetna, Excellus BlueCross BlueShield and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.